RA CAPITAL MANAGEMENT, L.P. - 09 Dec 2022 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
VOR
Transactions as of
09 Dec 2022
Net transactions value
+$50,000,000
Form type
4
Filing time
09 Dec 2022, 15:32:48 UTC
Previous filing
12 Dec 2022
Next filing
15 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Award $50,000,000 +11,627,907 +125% $4.30 20,923,554 09 Dec 2022 See Footnotes F1, F2, F4
holding VOR Common Stock 1,825,326 09 Dec 2022 See Footnotes F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer pursuant to the Securities Purchase Agreement dated December 7, 2022.
F2 Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F3 Held directly RA Capital Nexus Fund, L.P. (the "Nexus Fund").
F4 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Remarks:

Mr. Joshua Resnick, a Managing Director of the Adviser, serves on the Issuer's board of directors.